Piperacillin Sodium, Tazobactam Sodium · PIPERACILLIN SODIUM 36 g/152mL; TAZOBACTAM SODIUM 4.5 g/152mL · Injection, Powder, Lyophilized, For Solution · Intravenous · Sagent Pharmaceuticals
NDC 25021-0181-99 · 1 BOTTLE in 1 CARTON / 152 mL in 1 BOTTLE · ANDA · View full market →
Only one company currently supplies this market — there is no backup if it stumbles. Historically, drugs in this position went on to a new shortage within 90 days about 0.5% of the time — roughly 4× the typical drug (0.1%).
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Manufacturer list price as filed — not what pharmacies actually pay after discounts.
Not scored — fragility is computed for NADAC-priced NDCs.
sterile injectable · OAI inspection at a producing facility (24 months) · sole-source market
For scale: the typical drug’s chance is about 0.1% — this one is 4× that.
Backtested statistical model over the whole market, not this package alone. Model details →
There's no legal definition — it meets 1 of 6 public criteria. Why that matters →
No FDA shortage reports for this drug or its presentations.
No enforcement reports list this package NDC.
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Sagent Pharmaceuticals | PIPERACILLIN SODIUM 36 g/152mL; TAZOBACTAM SODIUM 4.5 g/152mL | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
DrugDashboards, "Piperacillin, Tazobactam — NDC 25021-0181-99," retrieved September 3, 2026, https://drugdashboards.com/drug/25021018199.
Free to cite with attribution — see how the data is put together.